RXRX
Recursion Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +30.0% ·
Aktienfluss +4.0% ·
neue Nettopositionen +20.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | -2 | 264.97M | $972.27M | +5 | −6 |
| Q1 2026 | 107 | +3 | 243.54M | $747.81M | +9 | −7 |
| Q4 2025 | 104 | +2 | 261.79M | $1.07B | +4 | −1 |
| Q3 2025 | 16 | -2 | 173.92M | $848.75M | — | −3 |
| Q2 2025 | 16 | 0 | 153.65M | $777.46M | — | — |
| Q1 2025 | 13 | +3 | 87.35M | $462.12M | +3 | — |
| Q4 2024 | 10 | 0 | 84.02M | $567.97M | — | — |
| Q3 2024 | 9 | +2 | 69.10M | $455.38M | +2 | — |
| Q2 2024 | 7 | — | 63.72M | $477.87M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 34.82M | +7.6% | $184.17M | 1.8% | ▲ Add | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 24.39M | -1.9% | $129.04M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 24.39M | -1.9% | $129.04M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 24.39M | -1.9% | $129.04M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 24.39M | -1.9% | $129.04M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passiv) | 13.09M | +4.0% | $69.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 6.44M | +5.9% | $34.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 6.44M | +5.9% | $34.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Norges Bank ✦ (passiv) | 3.41M | -1.6% | $18.05M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 2.66M | -3.0% | $14.05M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 1.15M | -30.6% | $6.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 502.11K | +1673.6% | $2.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 333.61K | Neu | $1.76M | 0.0% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 224.23K | +69.9% | $1.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 168.19K | Neu | $889,731 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 168.19K | Neu | $889,731 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 168.19K | Neu | $889,731 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 168.19K | Neu | $889,731 | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 107.48K | -6.5% | $568,548 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 107.48K | -6.5% | $568,548 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 107.48K | -6.5% | $568,548 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 107.48K | -6.5% | $568,548 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 60.91K | Neu | $322,193 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $1.76M | 0.0% |
| AQR Capital Management | $889,731 | 0.0% |
| AQR Capital Management | $889,731 | 0.0% |
| AQR Capital Management | $889,731 | 0.0% |
| AQR Capital Management | $889,731 | 0.0% |
| D. E. Shaw & Co. | $322,193 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 333 Inhaber, 334.81M Anteile, $1.02B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.